WallStreetZenWallStreetZen

NYSE: DOCS
DOXIMITY INC Stock Forecast, Predictions & Price Target

Analyst price target for DOCS

Based on 13 analysts offering 12 month price targets for DOXIMITY INC.
Min Forecast
$35.00+9.75%
Avg Forecast
$50.77+59.2%
Max Forecast
$74.00+132.05%

Should I buy or sell DOCS stock?

Based on 14 analysts offering ratings for DOXIMITY INC.
Buy
Strong Buy
5 analysts 35.71%
Buy
5 analysts 35.71%
Hold
3 analysts 21.43%
Sell
0 analysts 0%
Strong Sell
1 analysts 7.14%

DOCS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Anonymous
Goldman Sachs
Strong BuyMaintains$56.00+75.60%2022-05-19
Piper Sandler
Bottom 24%
24
Strong BuyMaintains$44.00+37.97%2022-05-19
Guggenheim
Top 10%
91
Strong BuyMaintains$52.00+63.06%2022-05-18
Jefferies
Top 28%
73
Strong BuyMaintains$46.00+44.25%2022-05-18
Raymond James
Bottom 1%
1
BuyMaintains$40.00+25.43%2022-05-18
Morgan Stanley
Bottom 27%
27
HoldMaintains$35.00+9.75%2022-05-18
Baird
Bottom 4%
4
BuyMaintains$45.00+41.11%2022-05-18
Needham
Bottom 5%
5
BuyMaintains$45.00+41.11%2022-05-18
SVB Leerink
Bottom 2%
2
BuyMaintains$67.00+110.10%2022-05-18
Bank of America
HoldInitiates Coverage On$55.00+72.47%2022-04-04

1 of 2

Forecast return on equity

Is DOCS forecast to generate an efficient return?
Company
N/A
Industry
10.01%
Market
30.86%

Forecast return on assets

Is DOCS forecast to generate an efficient return on assets?
Company
N/A
Industry
7.03%

DOCS earnings per share forecast

What is DOCS's earnings per share in the next 2 years based on estimates from 6 analysts?
Avg 1 year Forecast
$0.60
Avg 2 year Forecast
$0.69

DOCS revenue forecast

What is DOCS's revenue in the next 3 years based on estimates from 7 analysts?
Avg 1 year Forecast
$455.5M
Avg 2 year Forecast
$584.2M
Avg 3 year Forecast
$751.3M

DOCS vs Health Information Service Stocks

TickerPricePrice TargetUp/downsideConsensus
DOCS$31.89$50.77+59.20%Buy
RCM$21.16$28.60+35.16%Strong Buy
NUTX$8.39N/AN/A
TXG$45.72$161.67+253.60%Strong Buy
CHNG$23.10$25.80+11.69%Buy

DOXIMITY Stock Forecast FAQ

Is DOXIMITY Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 14 Wall Street analysts covering (NYSE: DOCS) stock is to Buy DOCS stock.

Out of 14 analysts, 5 (35.71%) are recommending DOCS as a Strong Buy, 5 (35.71%) are recommending DOCS as a Buy, 3 (21.43%) are recommending DOCS as a Hold, 0 (0%) are recommending DOCS as a Sell, and 1 (7.14%) are recommending DOCS as a Strong Sell.

What is DOCS's earnings growth forecast for 2023-2024?

(NYSE: DOCS) DOXIMITY's forecast annual earnings growth rate of N/A is not forecast to beat the US Health Information Services industry's average forecast earnings growth rate of 8.28%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.71%.

DOXIMITY's earnings in 2022 is N/A.On average, 6 Wall Street analysts forecast DOCS's earnings for 2023 to be $114,788,399, with the lowest DOCS earnings forecast at $86,091,300, and the highest DOCS earnings forecast at $172,182,599.

In 2024, DOCS is forecast to generate $132,006,659 in earnings, with the lowest earnings forecast at $110,962,119 and the highest earnings forecast at $170,269,459.

What is DOCS's revenue growth forecast for 2023-2025?

(NYSE: DOCS) DOXIMITY's forecast annual revenue growth rate of N/A is not forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 16.5%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 8.91%.

DOXIMITY's revenue in 2022 is N/A.On average, 7 Wall Street analysts forecast DOCS's revenue for 2023 to be $87,138,935,009, with the lowest DOCS revenue forecast at $85,723,976,672, and the highest DOCS revenue forecast at $87,526,154,543. On average, 7 Wall Street analysts forecast DOCS's revenue for 2024 to be $111,772,908,148, with the lowest DOCS revenue forecast at $109,906,448,774, and the highest DOCS revenue forecast at $112,978,568,969.

In 2025, DOCS is forecast to generate $143,740,712,125 in revenue, with the lowest revenue forecast at $140,997,078,065 and the highest revenue forecast at $147,371,086,570.

What is DOCS's forecast return on assets (ROA) for 2023-2025?

(NYSE: DOCS) forecast ROA is N/A, which is lower than the forecast US Health Information Services industry average of 7.03%.

What is DOCS's Price Target?

According to 13 Wall Street analysts that have issued a 1 year DOCS price target, the average DOCS price target is $50.77, with the highest DOCS stock price forecast at $74.00 and the lowest DOCS stock price forecast at $35.00.

On average, Wall Street analysts predict that DOXIMITY's share price could reach $50.77 by May 19, 2023. The average DOXIMITY stock price prediction forecasts a potential upside of 59.2% from the current DOCS share price of $31.89.

What is DOCS's Earnings Per Share (EPS) forecast for 2023-2024?

(NYSE: DOCS) DOXIMITY's current Earnings Per Share (EPS) is N/A. On average, analysts forecast that DOCS's EPS will be $0.60 for 2023, with the lowest EPS forecast at $0.45, and the highest EPS forecast at $0.90. In 2024, DOCS's EPS is forecast to hit $0.69 (min: $0.58, max: $0.89).

What is DOCS's forecast return on equity (ROE) for 2023-2025?

(NYSE: DOCS) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.